Hepcidin and iron parameters in children with anemia of chronic disease and iron deficiency anemia

Blood Research

Volumn 52, Issue 3, 2017, Pages 212-217

  Mahajan, Gunjan ^a   Sharma, Sunita ^a   Chandra, Jagdish ^a   Nangia, Anita ^a  

^a LADY HARDINGE MEDICAL COLLEGE   (India)

Author keywords

Anemia of chronic disease; Children; Hepcidin; Iron deficiency anemia

Indexed keywords

BIOLOGICAL MARKER; C REACTIVE PROTEIN; HEPCIDIN; INTERLEUKIN 6; IRON; TRANSFERRIN RECEPTOR;

ANEMIA; ANEMIA OF CHRONIC DISEASE; ARTICLE; AUTOIMMUNE DISEASE; BLOOD CELL COUNT; BLOOD SMEAR; CHILD; CLINICAL ARTICLE; CONTROLLED STUDY; ERYTHROCYTE COUNT; HEMATOLOGICAL PARAMETERS; HORMONE BLOOD LEVEL; HUMAN; INFECTION; IRON BLOOD LEVEL; IRON DEFICIENCY ANEMIA; IRON HOMEOSTASIS; MEAN CORPUSCULAR HEMOGLOBIN; MEAN CORPUSCULAR VOLUME; PROTEIN BLOOD LEVEL; RED CELL DISTRIBUTION;

EID: 85029825071     PISSN: 2287979X     EISSN: 22880011     Source Type: Journal    
DOI: 10.5045/br.2017.52.3.212     Document Type: Article

References (21)

1. Theurl I, Aigner E, Theurl M, et al. Regulation of iron homeostasis in anemia of chronic disease and iron deficiency anemia: diagnostic and therapeutic implications. Blood 2009;113:5277-86.
2. Kemna EH, Tjalsma H, Willems HL, Swinkels DW. Hepcidin: from discovery to differential diagnosis. Haematologica 2008; 93:90-7.
3. Krause A, Neitz S, Mägert HJ, et al. LEAP-1, a novel highly disulfide-bonded human peptide, exhibits antimicrobial activity. FEBS Lett 2000;480:147-50.
4. Park CH, Valore EV, Waring AJ, Ganz T. Hepcidin, a urinary antimicrobial peptide synthesized in the liver. J Biol Chem 2001;276:7806-10.
5. D'Angelo G. Role of hepcidin in the pathophysiology and diagnosis of anemia. Blood Res 2013;48:10-5.
6. Nemeth E, Rivera S, Gabayan V, et al. IL-6 mediates hypoferremia of inflammation by inducing the synthesis of the iron regulatory hormone hepcidin. J Clin Invest 2004;113:1271-6.
7. Wrighting DM, Andrews NC. Interleukin-6 induces hepcidin expression through STAT3. Blood 2006;108:3204-9.
8. World Health Organization. Iron deficiency anaemia assessment, prevention, and control: A guide for programme managers. Geneva, Switzerland: World Health Organization, 2001.
9. Jain S, Narayan S, Chandra J, Sharma S, Jain S, Malhan P. Evaluation of serum transferrin receptor and sTfR ferritin indices in diagnosing and differentiating iron deficiency anemia from anemia of chronic disease. Indian J Pediatr 2010;77:179-83.
10. Markovic M, Majkic-Singh N, Subota V. Usefulness of soluble transferrin receptor and ferritin in iron deficiency and chronic disease. Scand J Clin Lab Invest 2005;65:571-6.
11. Demirag MD, Haznedaroglu S, Sancak B, et al. Circulating hepcidin in the crossroads of anemia and inflammation associated with rheumatoid arthritis. Intern Med 2009;48:421-6.
12. van Santen S, van Dongen-Lases EC, de Vegt F, et al. Hepcidin and hemoglobin content parameters in the diagnosis of iron deficiency in rheumatoid arthritis patients with anemia. Arthritis Rheum 2011;63:3672-80.
13. Geerts I, Vermeersch P, Joosten E. Evaluation of the first commercial hepcidin ELISA for the differential diagnosis of anemia of chronic disease and iron deficiency anemia in hospitalized geriatric patients. ISRN Hematol 2012;2012:567491.
14. Casals-Pascual C, Huang H, Lakhal-Littleton S, et al. Hepcidin demonstrates a biphasic association with anemia in acute Plasmodium falciparum malaria. Haematologica 2012;97:1695-8.
15. Suega K. Role of hepcidin in mechanism of anemia chronic disease patients. Bali Med J 2014;3:89-96.
16. Choi HS, Song SH, Lee JH, Kim HJ, Yang HR. Serum hepcidin levels and iron parameters in children with iron deficiency. Korean J Hematol 2012;47:286-92.
17. Elgari MM, Al-Oufi F, AlSalmi M, Kurdi M, Ibrahim NA, Elmugadam A. Role of serum hepcidin levels in the diagnosis of iron deficiency anemia in children in Saudi Arabia. Am J Res Commun 2015;3:24-30.
18. Pasricha SR, McQuilten Z, Westerman M, et al. Serum hepcidin as a diagnostic test of iron deficiency in premenopausal female blood donors. Haematologica 2011;96:1099-105.
19. Girelli D, Nemeth E, Swinkels DW. Hepcidin in the diagnosis of iron disorders. Blood 2016;127:2809-13.
20. Song SN, Tomosugi N, Kawabata H, Ishikawa T, Nishikawa T, Yoshizaki K. Down-regulation of hepcidin resulting from long-term treatment with an anti-IL-6 receptor antibody (tocilizumab) improves anemia of inflammation in multicentric Castleman disease. Blood 2010;116:3627-34.
21. Sasu BJ, Cooke KS, Arvedson TL, et al. Antihepcidin antibody treatment modulates iron metabolism and is effective in a mouse model of inflammation-induced anemia. Blood 2010;115:3616-24.